MedVector

Follow-up with Jannette "JADE" Alicea and MedVector's Scott Stout and Ted Barduson from their podcast interviews over 1 year ago to see how we are progressing in #DEI and trial accessibility in our underserved populations. Listen to the original interviews here: https://lnkd.in/gzNwXr3x Bring your voice to the community. And lets work together for an inclusive and accepting #clinicalresearch industry. #CRPN; #CRPNCentral; #DEI; #Diversity

Dear MedVector Friends and Stakeholders, Great news, the industry seems to be at a tipping point, and we wanted to open the doors to smaller investors before the VC frenzy begins. ($500 minimum) Since our last StartEngine round, we've made a lot of progress in the buildout of MedVector. Specifically, we've: • Raised $1.5M from larger investors, for a total of $3.5 million total invested. • Signed NDAs with 9 of the top 15 pharmaceutical companies, with several proposals out. • Are the official partner of the State of Delaware for clinical research. During our last round, our valuation was $10M; today, the cap is $25M, so our early investors are doing great! If you'd like to participate, learn more, or simply watch our momentum grow, check out our campaign page below! (Note: Existing investors and early investors get bonuses.) All the best, Scott Stout MedVector CEO https://lnkd.in/edhdwiPk

Was good to catch up with Scott Stout at 🆘 SOS Save Our Sites and discuss community outreach and DCT https://lnkd.in/gxSWwHPr

MedVector recently attended the SOS Conference in Tucson and came away with a surprising takeaway. The concept of "pushing back" is necessary in so many aspects of life, from buying a car to paying taxes. Even in relationships, a little bit of "push back" can go a long way. However, we often avoid "pushing back" because we fear being seen as difficult or ungrateful. But the truth is, everyone appreciates it when it's done properly. This is especially true for clinical trial sites. We need to start advocating for innovation by "pushing back" on outdated practices and embracing new ones. Sites have more power than we realize, and it's time to use it. Let's say "no" to paper informed consents and "yes" to virtual visits. Let's embrace new technology and methods without getting stuck in the past. If we don't "push back," nothing will change. So let's start advocating for innovation and make a difference! #SOSConference #Innovation #ClinicalTrials #PushingBack Dan Sfera, Brad Hightower, Daniel Fox, MPH, PhD

Our article, “Improving Your Access to Clinical Trials,” by #CTFA partner and MedVector founder Scott Stout, answers these questions and more. Share it now so more patients can learn about the benefits of #clinicalresearch participation. https://lnkd.in/gb-2V37A